Influence of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade
暂无分享,去创建一个
[1] S. Rosenberg,et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Gough,et al. CTLA4 gene polymorphism and autoimmunity , 2005, Immunological reviews.
[3] S. Groshen,et al. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. O’Brien,et al. Cytotoxic T-Lymphocyte Antigen 4 Gene and Recovery from Hepatitis B Virus Infection , 2004, Journal of Virology.
[5] S. Abrams. Role of anti-CTLA-4 therapies in the treatment of cancer. , 2004, Current opinion in molecular therapeutics.
[6] N. Laird,et al. Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.
[7] Thomas A. Davis,et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] Thomas Davis,et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Pérez-Lezaun,et al. Association of the CTLA4 promoter region (−1661G allele) with type 1 diabetes in the South Moroccan population , 2003, Genes and Immunity.
[10] C. Polychronakos,et al. A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele* , 2002, The Journal of Biological Chemistry.
[11] R. Giscombe,et al. A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein , 2002, Genes and Immunity.
[12] D. Schaid,et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.
[13] Frank Dudbridge,et al. Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.
[14] M. Christian,et al. [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.
[15] Nick Orr,et al. Common genetic variation and human disease. , 2008, Advances in genetics.
[16] Brian Staats,et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..
[17] S Rozen,et al. Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.